Chemerin as a Novel Crevicular Fluid Marker of Patients With Periodontitis and Type 2 Diabetes Mellitus

Dogan S. B. , Balli U. , Dede F. O. , Sertoglu E., Tazegul K.

JOURNAL OF PERIODONTOLOGY, cilt.87, sa.8, ss.923-933, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 87 Konu: 8
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1902/jop.2016.150657
  • Sayfa Sayıları: ss.923-933


Background: The objectives of the present study are to: 1) determine whether gingival crevicular fluid (GCF) chemerin is a novel predictive marker for patients with chronic periodontitis (CP) with and without type 2 diabetes mellitus (t2DM); 2) analyze the relationship between chemerin and interleukin (IL)-6 in periodontally healthy individuals and in patients with CP and with and without t2DM; and 3) evaluate the effect of non-surgical periodontal therapy on GCF chemerin levels.